Compass Pathways' Angel Round

Compass Pathways raised a round of funding on December 14, 2017.

Compass Pathways' initiative is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression. …

Articles about Compass Pathways' Angel Round: